A detailed history of Annapolis Financial Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Annapolis Financial Services, LLC holds 161 shares of NVS stock, worth $18,613. This represents 0.01% of its overall portfolio holdings.

Number of Shares
161
Previous 161 -0.0%
Holding current value
$18,613
Previous $15,000 13.33%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$75.55 - $92.52 $2,946 - $3,608
-39 Reduced 19.5%
161 $0
Q3 2022

Oct 21, 2022

BUY
$74.61 - $87.26 $14,922 - $17,452
200 New
200 $15,000
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $3,586 - $3,965
-45 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$78.07 - $94.43 $3,513 - $4,249
45 New
45 $4,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Annapolis Financial Services, LLC Portfolio

Follow Annapolis Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annapolis Financial Services, LLC with notifications on news.